{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:23:56Z","timestamp":1784309036533,"version":"3.55.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["(NO. 82460918)"],"award-info":[{"award-number":["(NO. 82460918)"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Basic of Guizhou","award":["ZK [2024] General 404"],"award-info":[{"award-number":["ZK [2024] General 404"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-12804-y","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T06:40:25Z","timestamp":1754635225000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genetic evidence reveals phosphatidylcholine as a mediator in the causal relationship between omega-3 and multiple myeloma risk"],"prefix":"10.1038","volume":"15","author":[{"given":"Jian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"12804_CR1","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","volume":"111","author":"RA Kyle","year":"2008","unstructured":"Kyle, R. A. & Rajkumar, S. V. Multiple myeloma. Blood 111, 2962\u20132972 (2008).","journal-title":"Blood"},{"key":"12804_CR2","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/s42003-024-06918-8","volume":"7","author":"M Yu","year":"2024","unstructured":"Yu, M. et al. Aberrant NSUN2-mediated m5C modification of exosomal LncRNA MALAT1 induced RANKL-mediated bone destruction in multiple myeloma. Commun. Biol. 7, 1249 (2024).","journal-title":"Commun. Biol."},{"key":"12804_CR3","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar, S. V. et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 15, e538-548 (2014).","journal-title":"Lancet Oncol."},{"key":"12804_CR4","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 74, 229\u2013263 (2024).","journal-title":"CA: A Cancer J Clin."},{"key":"12804_CR5","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/ajh.27422","volume":"99","author":"SV Rajkumar","year":"2024","unstructured":"Rajkumar, S. V. Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management. Am. J. Hematol. 99, 1802\u20131824 (2024).","journal-title":"Am. J. Hematol."},{"key":"12804_CR6","doi-asserted-by":"publisher","first-page":"2314322","DOI":"10.1080\/15384047.2024.2314322","volume":"25","author":"H Wang","year":"2024","unstructured":"Wang, H. et al. CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells. Cancer Biol. Ther. 25, 2314322 (2024).","journal-title":"Cancer Biol. Ther."},{"key":"12804_CR7","doi-asserted-by":"publisher","first-page":"592s","DOI":"10.3945\/jn.111.155259","volume":"142","author":"PC Calder","year":"2012","unstructured":"Calder, P. C. Mechanisms of action of (n-3) fatty acids. J. Nutr. 142, 592s\u2013599s (2012).","journal-title":"J. Nutr."},{"key":"12804_CR8","first-page":"394","volume":"34","author":"J Aldoori","year":"2025","unstructured":"Aldoori, J., Zulyniak, M. A., Toogood, G. J. & Hull, M. A. Plasma n-3 polyunsaturated fatty acid levels and colorectal cancer risk in the UK biobank: Evidence of nonlinearity, as well as tumor site- and sex-specificity. Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol. 34, 394\u2013404 (2025).","journal-title":"Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol."},{"key":"12804_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2023.163552","volume":"882","author":"T Chen","year":"2023","unstructured":"Chen, T. et al. Dietary polyunsaturated fatty acids intake, air pollution, and the risk of lung cancer: A prospective study in UK biobank. Sci. Total Environ. 882, 163552 (2023).","journal-title":"Sci. Total Environ."},{"key":"12804_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f3706","volume":"346","author":"JS Zheng","year":"2013","unstructured":"Zheng, J. S., Hu, X. J., Zhao, Y. M., Yang, J. & Li, D. Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: Meta-analysis of data from 21 independent prospective cohort studies. BMJ 346, f3706 (2013).","journal-title":"BMJ"},{"key":"12804_CR11","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1186\/s12885-021-08804-6","volume":"21","author":"S Wu","year":"2021","unstructured":"Wu, S. et al. Effect of EPA on Hsp90 and GR\u03b1 protein expression in multiple myeloma drug-resistant cells. BMC Cancer 21, 1076 (2021).","journal-title":"BMC Cancer"},{"key":"12804_CR12","doi-asserted-by":"publisher","first-page":"426","DOI":"10.18632\/genesandcancer.131","volume":"8","author":"D D'Eliseo","year":"2017","unstructured":"D\u2019Eliseo, D., Di Renzo, L., Santoni, A. & Velotti, F. Docosahexaenoic acid (DHA) promotes immunogenic apoptosis in human multiple myeloma cells, induces autophagy and inhibits STAT3 in both tumor and dendritic cells. Genes Cancer 8, 426\u2013437 (2017).","journal-title":"Genes Cancer"},{"key":"12804_CR13","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s40199-020-00372-7","volume":"28","author":"M Moloudizargari","year":"2020","unstructured":"Moloudizargari, M., Redegeld, F., Asghari, M. H., Mosaffa, N. & Mortaz, E. Long-chain polyunsaturated omega-3 fatty acids reduce multiple myeloma exosome-mediated suppression of NK cell cytotoxicity. Daru 28, 647\u2013659 (2020).","journal-title":"Daru"},{"key":"12804_CR14","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1134\/S0006297917070082","volume":"82","author":"X Dai","year":"2017","unstructured":"Dai, X., Li, M. & Geng, F. Omega-3 polyunsaturated fatty acids eicosapentaenoic acid and docosahexaenoic acid enhance dexamethasone sensitivity in multiple myeloma cells by the p53\/miR-34a\/Bcl-2 axis. Biochemistry (Mosc) 82, 826\u2013833 (2017).","journal-title":"Biochemistry (Mosc)"},{"key":"12804_CR15","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1016\/j.clnu.2020.09.009","volume":"40","author":"J Chen","year":"2021","unstructured":"Chen, J., Garssen, J. & Redegeld, F. The efficacy of bortezomib in human multiple myeloma cells is enhanced by combination with omega-3 fatty acids DHA and EPA: Timing is essential. Clin. Nutr. 40, 1942\u20131953 (2021).","journal-title":"Clin. Nutr."},{"key":"12804_CR16","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3390\/cancers13030540","volume":"13","author":"T Choi","year":"2021","unstructured":"Choi, T. et al. Lipid level, lipid variability, and risk of multiple myeloma: A nationwide population-based study of 3,527,776 subjects. Cancers 13, 540 (2021).","journal-title":"Cancers"},{"key":"12804_CR17","doi-asserted-by":"publisher","first-page":"4852","DOI":"10.7150\/jca.31357","volume":"10","author":"L Liang","year":"2019","unstructured":"Liang, L., Li, J., Fu, H., Liu, X. & Liu, P. Identification of high serum apolipoprotein A1 as a favorable prognostic indicator in patients with multiple myeloma. J. Cancer 10, 4852\u20134859 (2019).","journal-title":"J. Cancer"},{"key":"12804_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12944-024-02289-5","volume":"23","author":"W Zhu","year":"2024","unstructured":"Zhu, W. et al. Lipid levels and multiple myeloma risk: insights from meta-analysis and Mendelian randomization. Lipids Health Dis. 23, 299 (2024).","journal-title":"Lipids Health Dis."},{"key":"12804_CR19","doi-asserted-by":"publisher","first-page":"25961","DOI":"10.1038\/s41598-024-74838-y","volume":"14","author":"Y Ding","year":"2024","unstructured":"Ding, Y., Zhang, Y., Zhang, X., Shang, M. & Dong, F. Association of lipid levels, adipokines and multiple myeloma: a two-sample multivariate Mendelian randomization study. Sci. Rep. 14, 25961 (2024).","journal-title":"Sci. Rep."},{"key":"12804_CR20","doi-asserted-by":"publisher","first-page":"1531928","DOI":"10.3389\/fonc.2025.1531928","volume":"15","author":"H Wang","year":"2025","unstructured":"Wang, H. et al. Lipid metabolism in multiple myeloma: pathogenesis, therapeutic opportunities, and future directions. Front. Oncol. 15, 1531928 (2025).","journal-title":"Front. Oncol."},{"key":"12804_CR21","doi-asserted-by":"publisher","first-page":"1439599","DOI":"10.3389\/fnut.2024.1439599","volume":"11","author":"F Mu","year":"2024","unstructured":"Mu, F., Wang, W., Liu, L., Hu, N. & Wang, F. Impact of omega-3 fatty acids supplementation on lipid levels in pregnant women with previous pregnancy losses: A retrospective longitudinal study. Front. Nutr. 11, 1439599 (2024).","journal-title":"Front. Nutr."},{"key":"12804_CR22","doi-asserted-by":"publisher","first-page":"20220928","DOI":"10.1515\/biol-2022-0928","volume":"19","author":"X Zhang","year":"2024","unstructured":"Zhang, X., Li, F., Yang, B., Zhang, W. & Wang, Y. Omega-3 fatty acids prevent gestational diabetes mellitus via modulation of lipid metabolism. Open Life Sci. 19, 20220928 (2024).","journal-title":"Open Life Sci."},{"key":"12804_CR23","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1016\/S0140-6736(04)16260-0","volume":"363","author":"DA Lawlor","year":"2004","unstructured":"Lawlor, D. A., Davey Smith, G., Kundu, D., Bruckdorfer, K. R. & Ebrahim, S. Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence?. Lancet (London, England) 363, 1724\u20131727 (2004).","journal-title":"Lancet (London, England)"},{"key":"12804_CR24","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1161\/CIRCULATIONAHA.117.028307","volume":"135","author":"N Sattar","year":"2017","unstructured":"Sattar, N. & Preiss, D. Reverse causality in cardiovascular epidemiological research: More common Than imagined?. Circulation 135, 2369\u20132372 (2017).","journal-title":"Circulation"},{"key":"12804_CR25","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1093\/aje\/kwm165","volume":"166","author":"Z Fewell","year":"2007","unstructured":"Fewell, Z., Davey Smith, G. & Sterne, J. A. The impact of residual and unmeasured confounding in epidemiologic studies: A simulation study. Am. J. Epidemiol. 166, 646\u2013655 (2007).","journal-title":"Am. J. Epidemiol."},{"key":"12804_CR26","first-page":"995","volume":"27","author":"J Yarmolinsky","year":"2018","unstructured":"Yarmolinsky, J. et al. Causal inference in cancer epidemiology: what is the role of Mendelian randomization?. Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol. 27, 995\u20131010 (2018).","journal-title":"Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol."},{"key":"12804_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12916-022-02246-y","volume":"20","author":"G Markozannes","year":"2022","unstructured":"Markozannes, G. et al. Systematic review of Mendelian randomization studies on risk of cancer. BMC Med. 20, 41 (2022).","journal-title":"BMC Med."},{"key":"12804_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s12916-023-03086-0","volume":"21","author":"Q Wang","year":"2023","unstructured":"Wang, Q., Shi, Q., Wang, Z., Lu, J. & Hou, J. Integrating plasma proteomes with genome-wide association data for causal protein identification in multiple myeloma. BMC Med. 21, 377 (2023).","journal-title":"BMC Med."},{"key":"12804_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies, N. M., Holmes, M. V. & Davey Smith, G. Reading Mendelian randomisation studies: A guide, glossary, and checklist for clinicians. BMJ 362, k601 (2018).","journal-title":"BMJ"},{"key":"12804_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12916-023-02894-8","volume":"21","author":"SL Au Yeung","year":"2023","unstructured":"Au Yeung, S. L. & Gill, D. Standardizing the reporting of Mendelian randomization studies. BMC Med. 21, 187 (2023).","journal-title":"BMC Med."},{"key":"12804_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001547","volume":"20","author":"TG Richardson","year":"2022","unstructured":"Richardson, T. G. et al. Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation. PLoS Biol. 20, e3001547 (2022).","journal-title":"PLoS Biol."},{"key":"12804_CR32","doi-asserted-by":"publisher","first-page":"6934","DOI":"10.1038\/s41467-023-42532-8","volume":"14","author":"L Ottensmann","year":"2023","unstructured":"Ottensmann, L. et al. Genome-wide association analysis of plasma lipidome identifies 495 genetic associations. Nat. Commun. 14, 6934 (2023).","journal-title":"Nat. Commun."},{"key":"12804_CR33","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1093\/aje\/kwr026","volume":"173","author":"TM Palmer","year":"2011","unstructured":"Palmer, T. M. et al. Instrumental variable estimation of causal risk ratios and causal odds ratios in Mendelian randomization analyses. Am. J. Epidemiol. 173, 1392\u20131403 (2011).","journal-title":"Am. J. Epidemiol."},{"key":"12804_CR34","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.jid.2019.03.1138","volume":"139","author":"A Budu-Aggrey","year":"2019","unstructured":"Budu-Aggrey, A. & Paternoster, L. Research techniques made simple: Using genetic variants for randomization. J. Investig. Dermatol. 139, 1416-1421.e1411 (2019).","journal-title":"J. Investig. Dermatol."},{"key":"12804_CR35","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden, J., Davey Smith, G., Haycock, P. C. & Burgess, S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet. Epidemiol. 40, 304\u2013314 (2016).","journal-title":"Genet. Epidemiol."},{"key":"12804_CR36","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.ajhg.2021.05.014","volume":"108","author":"H Xue","year":"2021","unstructured":"Xue, H., Shen, X. & Pan, W. Constrained maximum likelihood-based Mendelian randomization robust to both correlated and uncorrelated pleiotropic effects. Am. J. Hum. Genet. 108, 1251\u20131269 (2021).","journal-title":"Am. J. Hum. Genet."},{"key":"12804_CR37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12916-023-02982-9","volume":"21","author":"K Yu","year":"2023","unstructured":"Yu, K. et al. Assessment of bidirectional relationships between brain imaging-derived phenotypes and stroke: A Mendelian randomization study. BMC Med. 21, 271 (2023).","journal-title":"BMC Med."},{"key":"12804_CR38","volume":"39","author":"H Weng","year":"2023","unstructured":"Weng, H. et al. Association between uric acid and risk of venous thromboembolism in East Asian populations: A cohort and Mendelian randomization study. Lancet Reg. Health West Pac. 39, 100848 (2023).","journal-title":"Lancet Reg. Health West Pac."},{"key":"12804_CR39","doi-asserted-by":"publisher","first-page":"20964","DOI":"10.1002\/cam4.6649","volume":"12","author":"L Li","year":"2023","unstructured":"Li, L., Yu, Z., Ren, J. & Niu, T. Low cholesterol levels are associated with increasing risk of plasma cell neoplasm: A UK biobank cohort study. Cancer Med. 12, 20964\u201320975 (2023).","journal-title":"Cancer Med."},{"key":"12804_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-020-00963-6","volume":"13","author":"KM Pedersen","year":"2020","unstructured":"Pedersen, K. M., \u00c7olak, Y., Bojesen, S. E. & Nordestgaard, B. G. Low high-density lipoprotein and increased risk of several cancers: 2 population-based cohort studies including 116,728 individuals. J. Hematol. Oncol. 13, 129 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"12804_CR41","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s13679-025-00644-w","volume":"14","author":"L Manna","year":"2025","unstructured":"Manna, L. et al. Unraveling obesity and multiple myeloma: Insights from epidemiology and molecular mechanisms. Curr. Obes. Rep. 14, 52 (2025).","journal-title":"Curr. Obes. Rep."},{"key":"12804_CR42","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1530\/ERC-15-0029","volume":"22","author":"R R\u00edos","year":"2015","unstructured":"R\u00edos, R. et al. Type 2 diabetes-related variants influence the risk of developing multiple myeloma: Results from the IMMEnSE consortium. Endocr. Relat. Cancer 22, 545\u2013559 (2015).","journal-title":"Endocr. Relat. Cancer"},{"key":"12804_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2024.142498","volume":"470","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. Recent developments, challenges, and prospects of dietary omega-3 PUFA-fortified foods: Focusing on their effects on cardiovascular diseases. Food Chem. 470, 142498 (2025).","journal-title":"Food Chem."},{"key":"12804_CR44","doi-asserted-by":"crossref","unstructured":"Corrigendum to Association data to promote fish and omega-3 consumption for brain health: Caution required. Am. J. Clin. Nutr. 119, 1082\u20131083 (2024). Am J Clin Nutr 121, 502 (2025).","DOI":"10.1016\/j.ajcnut.2024.12.019"},{"key":"12804_CR45","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3945\/ajcn.114.098988","volume":"101","author":"TM Brasky","year":"2015","unstructured":"Brasky, T. M. et al. Long-chain \u03c9-3 fatty acid intake and endometrial cancer risk in the Women\u2019s Health Initiative. Am. J. Clin. Nutr. 101, 824\u2013834 (2015).","journal-title":"Am. J. Clin. Nutr."},{"key":"12804_CR46","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/advances\/nmaa055","volume":"11","author":"KH Lee","year":"2020","unstructured":"Lee, K. H. et al. Consumption of fish and \u03c9-3 fatty acids and cancer risk: An umbrella review of meta-analyses of observational studies. Adv. Nutr. 11, 1134\u20131149 (2020).","journal-title":"Adv. Nutr."},{"key":"12804_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2022.852643","volume":"3","author":"HA Bischoff-Ferrari","year":"2022","unstructured":"Bischoff-Ferrari, H. A. et al. Combined vitamin D, omega-3 fatty acids, and a simple home exercise program may reduce cancer risk among active adults aged 70 and older: A randomized clinical trial. Front. Aging 3, 852643 (2022).","journal-title":"Front. Aging"},{"key":"12804_CR48","doi-asserted-by":"publisher","first-page":"153473542412750","DOI":"10.1177\/15347354241275052","volume":"23","author":"AV Chua Jr","year":"2024","unstructured":"Chua, A. V. Jr., Hernandez, A. R. B., Mendoza, M. J. L. & San Juan, M. D. Omega-3 fatty acids increase weight and quality of life scores in patients with advanced non-small cell lung cancer and cancer cachexia: A meta-analysis. Integr. Cancer Ther. 23, 15347354241275052 (2024).","journal-title":"Integr. Cancer Ther."},{"key":"12804_CR49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s11658-025-00694-x","volume":"30","author":"V Marchio","year":"2025","unstructured":"Marchio, V. et al. Omega-3 fatty acids: Molecular weapons against chemoresistance in breast cancer. Cell. Mol. Biol. Lett. 30, 11 (2025).","journal-title":"Cell. Mol. Biol. Lett."},{"key":"12804_CR50","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1080\/01635581.2020.1743873","volume":"73","author":"Y Ma","year":"2021","unstructured":"Ma, Y., Wang, J., Li, Q. & Cao, B. The effect of omega-3 polyunsaturated fatty acid supplementations on anti-tumor drugs in triple negative breast cancer. Nutr. Cancer 73, 196\u2013205 (2021).","journal-title":"Nutr. Cancer"},{"key":"12804_CR51","first-page":"1085","volume":"37","author":"SH Wu","year":"2016","unstructured":"Wu, S. H. et al. Effects of \u03c9-3 polyunsaturated fatty acids on multiple myeloma growth inhibition and enhanced sensitivity of dexamethasone. Zhonghua Xue Ye Xue Za Zhi 37, 1085\u20131088 (2016).","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"12804_CR52","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.3390\/cells10092287","volume":"10","author":"J Chen","year":"2021","unstructured":"Chen, J. et al. Omega-3 fatty acids DHA and EPA reduce bortezomib resistance in multiple myeloma cells by promoting glutathione degradation. Cells 10, 2287 (2021).","journal-title":"Cells"},{"key":"12804_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174883","volume":"922","author":"J Chen","year":"2022","unstructured":"Chen, J., Ruijtenbeek, R., Garssen, J. & Redegeld, F. A. Esterified derivatives of DHA and EPA increase bortezomib cytotoxicity in human multiple myeloma cells. Eur. J. Pharmacol. 922, 174883 (2022).","journal-title":"Eur. J. Pharmacol."},{"key":"12804_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.907036","volume":"12","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. Cell death triggers induce MLKL cleavage in multiple myeloma cells, which may promote cell death. Front. Oncol. 12, 907036 (2022).","journal-title":"Front. Oncol."},{"key":"12804_CR55","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1021\/acschemneuro.3c00741","volume":"15","author":"C Gu","year":"2024","unstructured":"Gu, C., Philipsen, M. H. & Ewing, A. G. Omega-3 and -6 fatty acids alter the membrane lipid composition and vesicle size to regulate exocytosis and storage of catecholamines. ACS Chem. Neurosci. 15, 816\u2013826 (2024).","journal-title":"ACS Chem. Neurosci."},{"key":"12804_CR56","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1194\/jlr.M087734","volume":"59","author":"MH Philipsen","year":"2018","unstructured":"Philipsen, M. H., S\u00e4mfors, S., Malmberg, P. & Ewing, A. G. Relative quantification of deuterated omega-3 and -6 fatty acids and their lipid turnover in PC12 cell membranes using TOF-SIMS. J. Lipid Res. 59, 2098\u20132107 (2018).","journal-title":"J. Lipid Res."},{"key":"12804_CR57","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1126\/science.1255288","volume":"345","author":"M Pinot","year":"2014","unstructured":"Pinot, M. et al. Lipid cell biology. Polyunsaturated phospholipids facilitate membrane deformation and fission by endocytic proteins. Science 345, 693\u2013697 (2014).","journal-title":"Science"},{"key":"12804_CR58","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1006\/phrs.1999.0495","volume":"40","author":"LA Horrocks","year":"1999","unstructured":"Horrocks, L. A. & Yeo, Y. K. Health benefits of docosahexaenoic acid (DHA). Pharmacol. Res. 40, 211\u2013225 (1999).","journal-title":"Pharmacol. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12804-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12804-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12804-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T19:59:53Z","timestamp":1757361593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12804-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12804"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12804-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"6 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Each of the studies contributing to the GWAS obtained informed consent from study participants and ethical approval for data collection and analysis. Our study complied with all relevant ethical regulations, including the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"29016"}}